Evaluation of T and B lymphocyte function in clinical practice using a flow cytometry based proliferation assay

Clinical Immunology

Volumn 153, Issue 2, 2014, Pages 332-342

  Marits, Per ^a,b   Wikström, Ann Charlotte ^a,b   Popadic, Dusan ^c   Winqvist, Ola ^a,b   Thunberg, Sarah ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Flow cytometry; Lymphocyte proliferation assay; Primary immune deficiency

Indexed keywords

DEXAMETHASONE; MITOGENIC AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; POKEWEED MITOGEN; RADIOPHARMACEUTICAL AGENT; RAPAMYCIN; STAPHYLOCOCCUS ENTEROTOXIN A; STAPHYLOCOCCUS ENTEROTOXIN B; TACROLIMUS; THYMIDINE H 3; UNCLASSIFIED DRUG;

ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; BLOOD; CASE REPORT; CELL PROLIFERATION ASSAY; CELLULAR IMMUNITY; CLINICAL PRACTICE; CONTROLLED STUDY; DONOR; EVALUATION STUDY; FEMALE; FLOW CYTOMETRIC ASSAY FOR SPECIFIEC CELL MEDIATED IMMUNE RESPONSE IN ACTIVATED WHOLE BLOOD; FLOW CYTOMETRY; GOLD STANDARD; HUMAN; HUMAN CELL; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REFERENCE VALUE; SEVERE COMBINED IMMUNODEFICIENCY; T LYMPHOCYTE;

FLOW CYTOMETRY; LYMPHOCYTE PROLIFERATION ASSAY; PRIMARY IMMUNE DEFICIENCY;

B-LYMPHOCYTES; CELL PROLIFERATION; DEXAMETHASONE; ENTEROTOXINS; FLOW CYTOMETRY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; INTERLEUKIN-17; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; POKEWEED MITOGENS; REPRODUCIBILITY OF RESULTS; SEVERE COMBINED IMMUNODEFICIENCY; SIROLIMUS; T-LYMPHOCYTES; TACROLIMUS;

EID: 84902978026     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2014.05.010     Document Type: Article

References (26)

1. Taylor H.J., Woods P.S., Hughes W.L. The organization and duplication of chromosomes as revealed by autoradiographic studies using tritium-labeled thymidine. Proc. Natl. Acad. Sci. U. S. A. 1956, 43:122-128.
2. Wilson D.B., Blyth J.N.P. Quantitative studies on the mixed lymphocyte interaction in rats. 3. Kinetics of the response. J. Exp. Med. 1968, 128:1157-1181.
3. Porstmann T., Ternynck T., Avrameas S. Quantitation of 5-bromo-2-deoxyuridine incorporation into DNA: an enzyme immunoassay for the assessment of the lymphoid cell proliferative response. J. Immunol. Methods 1985, 82:169-179.
4. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
5. Lyons A.B., Parish C.R. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 1994, 171:131-137.
6. Cost K.M., Fineman D., Steger S. A flow cytometry-based screening assay for lymphocyte proliferation. Clin. Immunol. 1993, 13:82-85.
7. Gaines H., Andersson L., Biberfeld G. A new method for measuring lymphoproliferation at the single-cell level in whole blood cultures by flow cytometry. J. Immunol. Methods 1996, 195:63-72.
8. Arason G.J., Jorgensen G.H., Ludviksson B.R. Primary immunodeficiency and autoimmunity: lessons from human diseases. Scand. J. Immunol. 2010, 71:317-328.
9. Locke B.A., Dasu T., Verbsky J.W. Laboratory diagnosis of primary immunodeficiencies. Clin. Rev. Allergy Immunol. 2014, 46:154-168.
10. Chinen J., Notarangelo L.D., Shearer W.T. Advances in basic and clinical immunology in 2013. J. Allergy Clin. Immunol. 2014, 133:967-976.
11. Peavy D.L., Baughn R.E., Musher D.M. Mitogenic activity of bacterial lipopolysaccharides in vivo: morphological and functional characterization of responding cells. Infect. Immun. 1978, 19:71-78.
12. Dupont B., Good R.A. Lymphocyte transformation in vitro in patients with immunodeficiency diseases: use in diagnosis, histocompatibility testing and monitoring treatment. Birth Defects Orig. Artic. Ser. 1975, 11:477-485.
13. Stone K.D., Feldman H.A., Huisman C., Howlett C., Jabara H.H., Bonilla F.A. Analysis of in vitro lymphocyte proliferation as a screening tool for cellular immunodeficiency. Clin. Immunol. 2009, 131:41-49.
14. Gennery A.R., Cant A.J. Diagnosis of severe combined immunodeficiency. J. Clin. Pathol. 2001, 54:191-195.
15. Kurzawski M., Drozdzik M. Pharmacogenetics in solid organ transplantation: genes involved in mechanism of action and pharmacokinetics of immunosuppressive drugs. Pharmacogenomics 2013, 14:1099-1118.
16. Messele T., Roos M.T., Hamann D., Koot M., Fontanet A.L., Miedema F., Schellekens P.T., Rinke de Wit T.F. Nonradioactive techniques for measurement of in vitro T-cell proliferation: alternatives to the [(3)H]thymidine incorporation assay. Clin. Diagn. Lab. Immunol. 2000, 7:687-692.
17. Johnsen H.E., Madsen M. Lymphocyte subpopulations in man: B-cell stimulation induced by pokeweed mitogen and irradiated T cells. Scand. J. Immunol. 1979, 10:241-249.
18. Krowka J.F., Cuevas B., Maron D.C., Steimer K.S., Ascher M.S., Sheppard H.W. Expression of CD69 after in vitro stimulation: a rapid method for quantitating impaired lymphocyte responses in HIV-infected individuals. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1996, 11:95-104.
19. Carrasco J., Godelaine D., Van Pel A., Boon T., van der Bruggen P. CD45RA on human CD8 T cells is sensitive to the time elapsed since the last antigenic stimulation. Blood 2006, 108:2897-2905.
20. Foldes G., Mioulane M., Kodagoda T., Lendvai Z., Iqbal A., Ali N.N., Schneider M.D., Harding S.E. Immunosuppressive agents modulate function, growth, and survival of cardiomyocytes and endothelial cells derived from human embryonic stem cells. Stem Cells Dev. 2014, 23:467-476.
21. Chung Y.J., Lee J.I., Chong S., Seok J.W., Park S.J., Jang H.W., Kim S.W., Chung J.H. Anti-proliferative effect and action mechanism of dexamethasone in human medullary thyroid cancer cell line. Endocr. Res. 2011, 36:149-157.
22. Li J., Kim S.G., Blenis J. Rapamycin: one drug, many effects. Cell Metab. 2014, 19:373-379.
23. Nijhuis E.W., Hinloopen B., van Lier R.A., Nagelkerken L. Differential sensitivity of human naive and memory CD4+ T cells for dexamethasone. Int. Immunol. 1995, 7:591-595.
24. Pandolfi J., Baz P., Fernandez P., Discianni Lupi A., Payaslian F., Billordo L.A., Fainboim L., Arruvito L. Regulatory and effector T-cells are differentially modulated by dexamethasone. Clin. Immunol. 2013, 149:400-410.
25. Verma M., Awdishu L., Lane J., Park K., Bahur B., Lwin W., McGee H., Steiner R., Finn P., Perkins D. Impact of single immunosuppressive drug withdrawal on lymphocyte immunoreactivity. J. Surg. Res. 2014, 188:309-315.
26. Levitsky J., Gallon L., Miller J., Tambur A.R., Leventhal J., Flaa C., Huang X., Sarraj B., Wang E., Mathew J.M. Allospecific regulatory effects of sirolimus and tacrolimus in the human mixed lymphocyte reaction. Transplantation 2011, 91:199-206.